sermorelin and glp-1 together Comeback Creator Longevity Plan Personalized GLP-1 Medication (Injection)

The peptide suppresses pro-inflammatory cytokines including TNF-, IL-6, and TGF-, which are key drivers of chronic low-grade inflammation (inflammaging) in older skin

GLP-1 drug warnings and studies include: FDA label updates for Ozempic: The new label change in January 2025 warns that Ozempic is associated with gastrointestinal adverse reactions, sometimes severe. However, it does not specifically say Ozempic causes gastroparesis, also known as stomach paralysis

In particular, Jonas et al

Semaglutide , as a weekly injection, is sold as Ozempic for Type 2 diabetes and Wegovy for obesity the same molecule at slightly different doses

Furthermore, lipid intermediates in the omentum and ascites have been shown to inhibit T lymphocyte function, which may suppress the immune system's antitumor capacity [270]